HALO

Halozyme Therapeutics, Inc. (HALO)

Last Price$58.70.1%
Market Cap$7,434.7M

HALO Rating

Crunching data... Almost there!

HALO Intrinsic Value

Instantly access our exclusive intrinsic value analysis.
Get Access for FREE

HALO Share Price History

1W 2.8%
1M 9.0%
6M 2.2%
YTD 56.9%
1Y 67.4%
3Y 74.4%
5Y 178.1%
10Y 293.6%
Share Price
Drawdown
Total Return
vs SP500
vs NASDAQ
$40.0$45.0$50.0$55.0$60.0Mar'24Apr'24May'24Jun'24Jul'24Aug'24Sep'24Oct'24Nov'24Dec'24Jan'25Feb'25
Value Sense

HALO Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

HALO Stock Financials

HALO Income Statement Metrics

Crunching data... Almost there!

HALO Cash Flow Statement Metrics

Crunching data... Almost there!

HALO Income Statement Overview

Crunching data... Almost there!

HALO Balance Sheet Overview

Crunching data... Almost there!

HALO Stock Ratios

Crunching data... Almost there!

HALO Earnings Surprises

Crunching data... Almost there!

HALO Dividends

HALO Dividend Yield

Crunching data... Almost there!

HALO Dividend Per Share

Crunching data... Almost there!

Competing with HALO

Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!

FAQ

What is Halozyme Therapeutics, Inc. (HALO) stock rating?

As of today, Halozyme Therapeutics, Inc. has a stock rating of 8 (out of 10), which is considered Great.

is Halozyme Therapeutics, Inc. (HALO) a good stock to buy?

As of today, Halozyme Therapeutics, Inc. has a Great stock rating, which is 19.7% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.